OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway
Xiao Yu, Maode Wang, Jie Zuo, et al.
Life Sciences (2019) Vol. 236, pp. 116917-116917
Open Access | Times Cited: 23

Showing 23 citing articles:

Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
Manendra Singh Tomar, Ashok Kumar, Chhitij Srivastava, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188616-188616
Closed Access | Times Cited: 191

Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy
Yu Chong, Bo Yang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 129, Iss. 6, pp. 397-415
Open Access | Times Cited: 57

Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours—A Research Hypothesis
Wojciech Żwierełło, Agnieszka Maruszewska, Marta Skórka-Majewicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1558-1558
Open Access | Times Cited: 18

Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
Weiping Li, Xia Xu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16

Mesenchymal Transformation: The Rosetta Stone of Glioblastoma Pathogenesis and Therapy Resistance
Zulfikar Azam, Shing Shun Tony To, Bakhos A. Tannous
Advanced Science (2020) Vol. 7, Iss. 22
Open Access | Times Cited: 49

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
Laura-Marie Ammer, Arabel Vollmann‐Zwerenz, Viktoria Ruf, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2973-2973
Open Access | Times Cited: 49

Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics
Vignesh Balaji E, Keerthilatha M. Pai, K. Sreedhara Ranganath Pai
Cancers (2025) Vol. 17, Iss. 5, pp. 831-831
Open Access

Retracted: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
Yingxiao Cao, Xin Li, Shiqi Kong, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 9, pp. 5135-5145
Open Access | Times Cited: 34

Transcription Factors with Targeting Potential in Gliomas
Angeliki-Ioanna Giannopoulou, Dimitrios S. Kanakoglou, Christina Piperi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3720-3720
Open Access | Times Cited: 18

LncRNA LINC00511 Acts as an Oncogene in Colorectal Cancer via Sponging miR-29c-3p to Upregulate NFIA
Yinlong Hu, Ying Zhang, Meng Ding, et al.
OncoTargets and Therapy (2021) Vol. Volume 13, pp. 13413-13424
Open Access | Times Cited: 21

Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition
Moumita Kundu, Subhayan Das, Suvendu Nandi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166782-166782
Closed Access | Times Cited: 6

Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications
Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188667-188667
Closed Access | Times Cited: 15

SoxE group transcription factor Sox8 promotes astrocytic differentiation of neural stem/precursor cells downstream of Nfia
Jun Takouda, Sayako Katada, Takuya Imamura, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 6
Open Access | Times Cited: 14

Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type
Yingbo Huang, Alexander Ling, Siddhika Pareek, et al.
Translational research (2020) Vol. 230, pp. 98-110
Open Access | Times Cited: 15

LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells
Boyang Fan, Qian Zhang, Ning Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5

Functional profiling of murine glioma models highlights targetable immune evasion phenotypes
Nicholas Mikolajewicz, Nazanin Tatari, Jiarun Wei, et al.
Research Square (Research Square) (2024)
Open Access

Functional profiling of murine glioma models highlights targetable immune evasion phenotypes
Nicholas Mikolajewicz, Nazanin Tatari, Jiarun Wei, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access

miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition
John R. Jacob, Rajbir Singh, Masa Okamoto, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108650-108650
Open Access | Times Cited: 1

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
Rui Tao, Qi Liu, Ruoyu Huang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 1

Molecular mechanisms in temozolomide-resistant glioblastoma
Sang Yup Lee, Gaspar J. Kitange
Elsevier eBooks (2021), pp. 79-133
Closed Access | Times Cited: 1

Page 1

Scroll to top